Back
Protagonist Therapeutics, Inc. Stock Price Chart
Last Call Before the Surge
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radin
Buy
53
PTGX
Protagonist Therapeutics, Inc.
Last Price:
$84.56
Seasonality Move:
9.35%
7 Day Trial
ALL ACCESS PASS
$
7
The Next AI Boom Won't Be Chips. It'll Be Software-And This Startup Is Leading It.
*DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PTGX is experiencing slight buying pressure.
Protagonist Therapeutics, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 82.34 | Buy |
| 20-day SMA: | 78.61 | Buy |
| 50-day SMA: | 71.05 | Buy |
| 200-day SMA: | 54.55 | Buy |
| 8-day EMA: | 82.51 | Buy |
| 20-day EMA: | 79.14 | Buy |
| 50-day EMA: | 72.6 | Buy |
| 200-day EMA: | 57.7 | Buy |
Protagonist Therapeutics, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 3.63 | Buy |
| Relative Strength Index (14 RSI): | 65.62 | Buy |
| Chaikin Money Flow: | 247874 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (74.99 - 81.75) | Buy |
| Bollinger Bands (100): | (52.8 - 73.32) | Buy |
Protagonist Therapeutics, Inc. Technical Analysis
| Nov 3 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 10 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 03 | 04 | 05 | 06 | 07 | 10 | 11 | 12 | 13 | 14 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Protagonist Therapeutics, Inc. Stock
Is Protagonist Therapeutics, Inc. Stock a Buy?
-
Protagonist Therapeutics, Inc. share price is 84.61 while PTGX 8-day simple moving average is 82.34, which is a Buy signal.
-
The stock price of PTGX is 84.61 while Protagonist Therapeutics, Inc. 20-day SMA is 78.61, which makes it a Buy.
-
Protagonist Therapeutics, Inc. 50-day simple moving average is 71.05 while PTGX share price is 84.61, making it a Buy technically.
-
PTGX stock price is 84.61 and Protagonist Therapeutics, Inc. 200-day simple moving average is 54.55, creating a Buy signal.
PTGX Technical Analysis vs Fundamental Analysis
Buy
53
Protagonist Therapeutics, Inc. (PTGX)
is a Buy
Is Protagonist Therapeutics, Inc. a Buy or a Sell?
-
Protagonist Therapeutics, Inc. stock is rated a BuyThe current Protagonist Therapeutics, Inc. [PTGX] share price is $84.61. The Score for PTGX is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.
Protagonist Therapeutics, Inc. Stock Info
Market Cap:
5.3B
Price in USD:
84.61
Share Volume:
755.4K
Protagonist Therapeutics, Inc. 52-Week Range
52-Week High:
93.25
52-Week Low:
33.31
Buy
53
Protagonist Therapeutics, Inc. (PTGX)
is a Buy
Protagonist Therapeutics, Inc. Share Price Forecast
-
What is the Protagonist Therapeutics, Inc. stock price today?The Protagonist Therapeutics, Inc. stock price is 84.61 USD today.
-
Will PTGX stock go up or go down?Protagonist Therapeutics, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is Protagonist Therapeutics, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Protagonist Therapeutics, Inc. is not overvalued.
Is Protagonist Therapeutics, Inc. Stock a Buy?
-
Protagonist Therapeutics, Inc. share price is 84.61 while PTGX 8-day exponential moving average is 82.51, which is a Buy signal.
-
The stock price of PTGX is 84.61 while Protagonist Therapeutics, Inc. 20-day EMA is 79.14, which makes it a Buy.
-
Protagonist Therapeutics, Inc. 50-day exponential moving average is 72.60 while PTGX share price is 84.61, making it a Buy technically.
-
PTGX stock price is 84.61 and Protagonist Therapeutics, Inc. 200-day simple moving average is 57.70, creating a Buy signal.
Fundamental Analysis of Protagonist Therapeutics, Inc.
Is Protagonist Therapeutics, Inc. a good investment?
-
Analysts estimate an earnings decrease this quarter of $1.01 per share, a decrease next quarter of $0.00 per share, a decrease this year of $4.50 per share, and an increase next year of $2.19 per share.
Technical Analysis of Protagonist Therapeutics, Inc.
Should I short Protagonist Therapeutics, Inc. stock?
-
PTGX Moving Average Covergence Divergence (MACD) indicator is 3.63, suggesting Protagonist Therapeutics, Inc. is a Buy
-
Protagonist Therapeutics, Inc. Relative Strength Index (RSI) is 65.62, which suggest Protagonist Therapeutics, Inc. is overbought
-
The Bollinger Bands (25) for Protagonist Therapeutics, Inc. is (74.99 - 81.75), which suggest Protagonist Therapeutics, Inc. is a Buy
-
The Bollinger Bands (100) for Protagonist Therapeutics, Inc. is (52.8 - 73.32), which suggest Protagonist Therapeutics, Inc. is a Buy
* Protagonist Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.